Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

324
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
324
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

250
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250
Obesity01:24

Obesity

1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

315
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
315
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.3K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aortopathy in Bicuspid Aortic Valve: Pathophysiology, Risk Stratification and Surgical Decision-Making-A Narrative Review.

Journal of clinical medicine·2026
Same author

Maternal Omega-3 PUFA Supplementation and Mitochondrial Function in a Newborn Piglet Model: A Preliminary Investigation.

International journal of molecular sciences·2026
Same author

Total Thrombus-Formation Analysis System (T-TAS) in Aortopathies: A Conceptual and Potential Framework to Spatial Heterogeneity and Regional Context.

International journal of molecular sciences·2026
Same author

Diet-Microbiome-Redox Interactions and Oxidative Stress Biomarkers in Livestock: Computational and Spatial Perspectives for Translational Health and Production.

International journal of molecular sciences·2026
Same author

Outcomes of Heart Transplantation in Single-Ventricle Physiology: A Retrospective Single-Center Experience with Emphasis on Surgical Complexity.

Journal of clinical medicine·2026
Same author

Serum Cytokine Profiles Associated with Inflammation and Tumor Progression in Crohn's Disease and Colorectal Cancer.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Feb 28, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K

Methodological and Pathophysiological Considerations in Obesity-Associated Thrombosis.

Julia Gniewek1, Sebastian Krych1,2, Marta Stępień-Słodkowska3

  • 1Student's Scientific Society, Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, School of Medical Sciences in Zabrze, Medical University of Silesia, Marii Skłodowskiej-Curie 9, 41-800 Zabrze, Poland.

International Journal of Molecular Sciences
|February 27, 2026
PubMed
Summary

Obesity elevates thrombosis risk via oxidative stress and hemostatic issues. The Total Thrombus-Formation Analysis System (T-TAS) combined with oxidative stress markers offers a new way to assess this risk.

Keywords:
Total Thrombus-Formation Analysis System (T-TAS)antioxidant capacityarterial thrombosisathletesbiomarkersfibrinhemostasisobesityoxidative stressplatelet functionspatial managementsports physiologythrombosisvenous thrombosis

More Related Videos

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
03:02

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

415
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

26.0K

Related Experiment Videos

Last Updated: Feb 28, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.4K
Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
03:02

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas

Published on: November 11, 2025

415
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
07:46

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation

Published on: April 3, 2017

26.0K

Area of Science:

  • Cardiovascular Science
  • Hematology
  • Metabolic Disorders

Background:

  • Obesity is a significant risk factor for venous and arterial thrombosis.
  • Chronic oxidative stress and hemostatic dysregulation are key mechanisms linking obesity to thrombosis.
  • Excess adipose tissue promotes inflammation and endothelial dysfunction, creating a prothrombotic state.

Purpose of the Study:

  • To review the link between obesity-induced oxidative stress and hemostatic disturbances.
  • To highlight the potential of the Total Thrombus-Formation Analysis System (T-TAS) in assessing thrombosis risk.
  • To explore how understanding redox imbalance and flow conditions can inform new therapeutic strategies.

Main Methods:

  • Review of current evidence linking obesity, oxidative stress, and thrombosis.
  • Description of the Total Thrombus-Formation Analysis System (T-TAS) as a flow-based thrombosis assessment platform.
  • Integration of oxidative stress biomarkers with T-TAS functional readouts for risk evaluation.

Main Results:

  • Obesity-induced oxidative stress leads to molecular alterations promoting a prothrombotic state.
  • T-TAS provides sensitive assessment of prothrombotic phenotypes by integrating platelet function, coagulation, and thrombus stability.
  • Combining oxidative stress markers with T-TAS data allows for multidimensional thrombosis risk evaluation in obese individuals.

Conclusions:

  • Obesity-induced oxidative stress significantly contributes to hemostatic dysregulation and thrombosis.
  • The T-TAS offers a valuable tool for mechanistic studies and clinical risk stratification of thrombosis in obesity.
  • Further understanding of redox imbalance and flow dynamics is crucial for developing novel preventive strategies against obesity-related thromboembolic events.